NXTpsychedelics provides opinion and commentary, equity research and newsletters focused on the psychedelics sector and on what matters in today's economy.
Cantheon Provides Funding to Albert Labs for Psilocybin Drug Development
Canadian biopharmaceutical company Albert Labs International Corp. secured a C$830,000 ($621,600)
#psychedelics#PsychTwitter#psilocybin
https://t.co/li3ZlUZ2uc
The Science of Psychedelics & Spiritual Medicine Conference
Are you ready to explore the fascinating world of psychedelics and spiritual medicine?
#psychedelics#PsychTwitter#psilocybin
https://t.co/fFVmWWcSxV
Washington House Panel Amends Psilocybin Research Bill To Add Patient Access Provisions Back In
A House committee in Washington State has amended and approved a psilocybin bill—inserting some therapeutic access provisions back into the legislation
https://t.co/jnUczyYRVm
Missouri House Advances Therapeutic Psilocybin Legalization And Research Bill
The Missouri House is one step closer to passing a bill that would legalize psilocybin therapy for certain patients while promoting research into the
#psychedelics
https://t.co/RpVy0F9LJL
Joël Brierre Calls To Those Seeking Transformation – Podcast Episode #24
On the season three premiere of the Psychedelic Invest Podcast, host Bruce Eckfeldt is joined by Joël Brierre.
#psychedelics#PsychTwitter#psilocybin
https://t.co/FGet2MLLmW
Psilocybin Therapies Attract Support in Illinois Legislature
A coalition behind Illinois’ proposed CURE Act is proposing the statewide legalization of psilocybin and psilocybin therapy sparked by collaboration between a
#psychedelics#PsychTwitter
https://t.co/LRQRPulEVB
Massachusetts Republican Wants to Cap Potential MDMA Therapy Costs
A Republican lawmaker in Massachusetts introduced a bill that would both reschedule the psychedelic MDMA at the state level and cap possible therapy costs at
#psychedelics
https://t.co/9j3UsmU3rt
PharmaTher Announces Positive FDA Meeting; Path Towards Phase 3 Trial
The article PharmaTher Announces Positive FDA Meeting; Path Towards Phase 3 Trial was originally published on Microdose.
#psychedelics#PsychTwitter#psilocybin
https://t.co/rZWZPTHs2g
PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, “Peace of Mind”
PSYC Corporation (OTC Pink Market: PSYC), parent company to Spotlight Media Corporation (“SMC”
#psychedelics#PsychTwitter#psilocybin
https://t.co/T2pMGxIjjy
Atai CEO Answers Questions From the Public
The article Atai CEO Answers Questions From the Public was originally published on Microdose.
Reddit is the internet incarnate.
#psychedelics#PsychTwitter#psilocybin
https://t.co/EV5EklibOm
PSYC’s CEO to Moderate Panel at Film Screening for ESPN’s Upcoming Documentary, "Peace of Mind"
LAS VEGAS, NV, March 29, 2023 (GLOBE NEWSWIRE) -- PSYC Corporation (OTC Pink Market: PSYC) (“PSYC”,
#psychedelics#PsychTwitter#psilocybin
https://t.co/z3IxQYciCQ
BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article
VANCOUVER, British Columbia, March 29, 2023 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (
https://t.co/zNclGUp57m
PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease
#psychedelics#PsychTwitter#psilocybin
https://t.co/Zm9mRkP4Sm
DE cannabis bills head to gov’s desk (Newsletter: March 29, 2023)
KY gov pushes lawmakers on medical marijuana; Congressman slams fed laws; SC medical bill in danger; Colombian legalization vote; Military drug
#psychedelics#PsychTwitter#psilocybin
https://t.co/Ox1nzGfzBb
Shifting Strategy, MAPS Turns to Equity Investment
The non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) has for the first time offered to sell shares in its for-profit, drug-development
#psychedelics#PsychTwitter#psilocybin
https://t.co/4sglAj8pHy
South Carolina Medical Marijuana Legalization Bill’s Fate In Question, But Supporters Are Making A Last-Ditch Push
South Carolina lawmakers and advocates aren’t giving up the push to legalize medical marijuana just yet, and they’re imploring leadership
https://t.co/OLy3cPOJzx
Massachusetts Bill Would Cap MDMA Therapy Costs at $5,000
The article Massachusetts Bill Would Cap MDMA Therapy Costs at $5,000 was originally published on Microdose.
#psychedelics#PsychTwitter#psilocybin
https://t.co/crmpdFfx2k
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
Upon the closing which occurred on March 22, 2023, the purchase price was adjusted from $2.5 million and increased to approximately $3 million.
https://t.co/B7JRUjQM0v
Why Did Liontown Reject A $3.7-Billion Buyout Offer From Albemarle?
Liontown Resources (ASX: LTR) said on Tuesday that it had rejected a non-binding indicative approach from top lithium producer Albemarle Corp (NYSE:
#psychedelics#PsychTwitter
https://t.co/ZHQnUKIRqY